Laura F. Gibson, Ph.D., senior associate vice president for research and graduate education at WVU Health Sciences, has been selected as a fellow in the Hedwig van Ameringen Executive Leadership in Academic Medicine® Program for Women at Drexel University College of Medicine.
The ELAM® fellow program serves to recognize senior women who demonstrate the greatest level of potential for executive leadership positions at academic health centers. ELAM is the only longitudinal program in North America dedicated to preparing women for senior leadership roles at schools of medicine, dentistry, public health and pharmacy where they can effect positive change on their institution.
Gibson is recognized as an outstanding leader, researcher, mentor and educator. She also serves as associate dean for research in the School of Medicine and as the Alexander B. Osborn Distinguished Professor in Hematological Malignancies. Her current focus in on optimizing research infrastructure at the Health Sciences Center and collaborating with University leadership to contribute to an optimal scientific work environment.
ELAM is a core program of Drexel University College of Medicine in Philadelphia, Pa. The program continues the legacy of advancing women in medicine that began in 1850 with the founding of the Female Medical College of Pennsylvania, the nation’s first women’s medical school and a predecessor of today’s Drexel University College of Medicine. For more information on the ELAM program curriculum, faculty and participants, visit www.drexel.edu/elam.
W est Virginia University’s Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator. A native of upstate New York, the renowned gastrointestinal cancer expert came to Morgantown about two years ago. Goldberg previously worked at The Ohio State University’s Wexner Medical Center, where he served as the Klotz Family Professor of Cancer Research, the physician‐in‐ chief of the James Cancer Hospital, the associate director of the Ohio State Comprehensive Cancer Center and the acting division director of the Division of Medical Oncology. Before that, he also worked at the University of North Carolina and the Mayo Clinic. Goldberg is one of many world-class physicians recruited by WVU Medicine during the past few years, whose research has resulted in more than 300 peer-reviewed publications, including those in the New England Journal of Medicine, the Journal of the American Medical Association and the Journal of Clinical Oncology
WVU Heart and Vascular Institute among top sites in innovative pilot study to improve outcomes of heart attacks
The WVU Heart and Vascular Institute was a leading site in a national pilot study assessing a new treatment for patients experiencing a myocardial infarction, or heart attack. The door to unload (DTU) trial was presented yesterday (Oct. 11) as a late breaking clinical trial at the American Heart Association Scientific Sessions 2018.
Surgeons at the WVU Rockefeller Neuroscience Institute have performed the state’s first laser interstitial thermal therapy (LiTT) procedure for drug-resistant epilepsy caused by focal seizures.